データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
データなし
Press Release: Gelteq Appoints Dr. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel Technology
Gelteq Receives FDA Approval of Its Suitability Petition for New Animal Drug
Gelteq Limited Shares Halted To The Upside; Stock Now Up 49.44%
Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Top Premarket Decliners